Innovations in Diagnosis of Schizophrenia
Abstract
Son yıllarda şizofreninin tanı ve tedavisinde birçok yenilikçi gelişme yaşanmıştır. Bu yazıda, şizofreni ile ilgili 20 yılı aşkın sürede edindiğim birikimleri güncel literatür ışığında başta Editör’e olmak üzere tüm okuyuculara sunmak istiyorum. Şizofreni, dünya genelindeki nüfusun yaklaşık %1'ini etkileyen, en fazla yeti yitimine yol açan, karmaşık ve kronik bir ruhsal bozukluktur...
References
Goldner EM, Hsu L, Waraich P, Somers JM. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry 2002;47(9):833–843.
Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014;15(8):509–524. doi: 10.1038/nrm3838.
Huang Y, Shen XJ, Zou Q, et al. Biological functions of microRNAs: a review. J Physiol Biochem 2011;67(1):129–139.
Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci 2010;12(3):271–287.
Jonas S, Izaurralde E. Towards a molecular understanding of microRNAmediated gene silencing. Nat Rev Genet 2015;16(7):421–433. doi: 10.1038/nrg3965.
Keshavan MS, Collin G, Guimond S, et al. Neuroimaging in Schizophrenia. Neuroimaging Clin N Am 2020;30(1):73-83. doi: 10.1016/j.nic.2019.09.007.
Li K, Zhu L, Lv H, et al. The Role of microRNA in Schizophrenia: A Scoping Review. Int J Mol Sci 2024;25(14):7673. doi: 10.3390/ijms25147673.
Lin J, Li J, Huang B, et al. Exosomes: novel biomarkers for clinical diagnosis. ScientificWorldJournal. 2015;2015:657086. doi: 10.1155/2015/657086.
Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009;9(21):4997–5000. doi: 10.1002/pmic.200900351.
Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 18;200(4):373–383. doi: 10.1083/jcb.201211138.
Santiago-Dieppa DR, Steinberg J, Gonda D, et al. Extracellular vesicles as a platform for ‘‘liquid biopsy”in glioblastoma patients. Expert Rev Mol Diagn 2014;14(7):819–825. doi: 10.1586/14737159.2014.943193.
Shboul M, Bani Domi A, Abu Zahra A, et al. Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort. Non-coding RNA Res 2024;9(2):350–358. doi: 10.1016/j.ncrna.2024.01.018.
Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009;6(3):267–283. doi: 10.1586/epr.09.17.
Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia,‘‘just the facts” 4. Clinical features and conceptualization. Schizophr Res 2009;110(1):1–23.
Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002;2(8):569–579. doi: 10.1038/nri855.
Torrey EF. Prevalence studies in schizophrenia. Br J Psychiatry 1987;150(5):598–608.
Treiber T, Treiber N, Meister G, et al. Regulation of microRNA biogenesis and function. Thromb Haemost 2012;107(4):605–10. doi: 10.1160/TH11-12-0836.
Weickert CS, Weickert TW, Pillai A, Buckley PF. Biomarkers in schizophrenia: a brief conceptual consideration. Dis Markers 2013;35(1):3–9. doi: 10.1155/2013/510402.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Melike Nebioğlu Yıldız
This work is licensed under a Creative Commons Attribution 4.0 International License.
